Get 20% lifetime commission for referring investors to digrin.com
here.
Sutro Biopharma, Inc. ( STRO) - Key Metrics
STRO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.59 | -$2.33 | -$2.31 | -$2.31 |
| 2026Q1 | $1.11 | -$2.94 | -$3.23 | -$3.23 |
| 2025Q4 | $1.36 | -$5.45 | -$3.08 | -$3.10 |
| 2025Q3 | $1.14 | -$6.70 | -$4.50 | -$4.53 |
| 2025Q2 | $7.54 | -$1.36 | -$5.29 | -$5.30 |
STRO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.56 |
| 2026Q1 | 0% | -2.12 |
| 2025Q4 | 0% | -0.53 |
| 2025Q3 | 0% | -0.32 |
| 2025Q2 | 0% | -1.28 |
STRO
Price: $22.28
52 week price:
Earnings Per Share: -17.37 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 223541
Market Capitalization: 339.6 million